53
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Quantifying the prognostic significance of microRNA-17/17-5P in cancers: a meta-analysis based on published studies

, , , , , & show all
Pages 2055-2069 | Published online: 17 Jul 2018

References

  • SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
  • SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin2016661726742998
  • ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
  • SunKLaiECAdult-specific functions of animal microRNAsNat Rev Genet201314853554823817310
  • LuJGetzGMiskaEAMicroRNA expression profiles classify human cancersNature2005435704383483815944708
  • AmbrosVThe functions of animal microRNAsNature2004431700635035515372042
  • WinbanksCEOoiJYNguyenSSMcMullenJRBernardoBCMicroRNAs differentially regulated in cardiac and skeletal muscle in health and disease: Potential drug targets?Clin Exp Pharmacol Physiol201441972773725115402
  • VorvisCKoutsioumpaMIliopoulosDDevelopments in miRNA gene signaling pathways in pancreatic cancerFuture Oncol20161291135115026984178
  • LinCWLinPYYangPCNoncoding RNAs in tumor epithelial-to-mesenchymal transitionStem Cells Int20162016273270526989421
  • WalterRFHVollrechtCWernerRMicroRNAs are differentially regulated between MDM2-positive and negative malignant pleural mesotheliomaOncotarget2016714187131872126918730
  • TreeceALDuncanDLTangWGastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein–Barr virus-related expression patternsLab Invest201696666126950485
  • GomesBCSantosBRueffJRodriguesASMethods for studying microRNA expression and their targets in formalin-fixed, paraffin-embedded (FFPE) breast cancer tissuesMethods Mol Biol2016139518920526910075
  • WenJYeFHeXDevelopment and validation of a prognostic nomogram based on the log odds of positive lymph nodes (LODDS) for breast cancerOncotarget2016715210462105326992235
  • KogaYYamazakiNYamamotoYFecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood testCancer Epidemiol Biomarkers Prev201322101844185223950216
  • TangYZhangYChenYXiangYShenCLiYThe role of miR-19b in the inhibition of endothelial cell apoptosis and its relationship with coronary artery diseaseSci Rep201551513226459935
  • FangYXuCFuYMicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signalingJ Biol Res (Thessalon)2015221211025984506
  • CohenRGreenbergENemlichYSchachterJMarkelGmiR-17 regulates melanoma cell motility by inhibiting the translation of ETV1Oncotarget2015622190061901626158900
  • JinYYAndradeJWickstromENon-specific blocking of miR-17-5p guide strand in triple negative breast cancer cells by amplifying passenger strand activityPloS one20151012e014257426629823
  • StroupDFBerlinJAMortonSCMeta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) groupJAMA2000283152008201210789670
  • MoherDLiberatiATetzlaffJAltmanDGPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementAnn Intern Med2009151426426919622511
  • ParmarMKTorriVStewartLExtracting summary statistics to perform meta-analyses of the published literature for survival endpointsStat Med19981724281528349921604
  • TierneyJFStewartLAGhersiDBurdettSSydesMRPractical methods for incorporating summary time-to-event data into meta-analysisTrials2007811617555582
  • WellsGSheaBO’ConnellDThe Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-AnalysesOttawa, ON, CanadaThe Ottawa Hospital Research Institute2011
  • HaydenJAvan der WindtDACartwrightJLCôtéPBombardierCAssessing bias in studies of prognostic factorsAnn Intern Med2013158428028623420236
  • DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
  • ThompsonSGHigginsJPHow should meta-regression analyses be undertaken and interpreted?Stat Med200221111559157312111920
  • MantelNHaenszelWStatistical aspects of the analysis of data from retrospective studies of diseaseJ Natl Cancer Inst195922471974813655060
  • BeggCBMazumdarMOperating characteristics of a rank correlation test for publication biasBiometrics1994504108811017786990
  • EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
  • YangFYuanLXuLmiR-17 as a diagnostic biomarker regulates cell proliferation in breast cancerOnco Targets Ther20171054355028203087
  • LiSGaoYWangYSerum microRNA-17 functions as a prognostic biomarker in osteosarcomaOncol Lett20161264905491028105199
  • RobainaMCFaccionRSMazzoccoliLmiR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosisAnn Hematol201695688189127044389
  • XiYLiJZhangPUpregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphomaExp Mol Pathol201599229730226231295
  • XuXLJiangYHFengJGSuDChenPCMaoWMMicroRNA-17, microRNA-18a, and microRNA-19a are prognostic indicators in esophageal squamous cell carcinomaAnn Thorac Surg20149731037104524360091
  • ChangCCYangYJLiYJCorrigendum to “MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma” [Oral Oncol499201392393123602254
  • Oral Oncol20177220220328711305
  • LuSWangSGengSMaSLiangZJiaoBIncreased expression of microRNA-17 predicts poor prognosis in human gliomaJ Biomed Biotechnol2012201297076123226946
  • GaoXZhangRQuXmiR-15a, miR-16-1 and miR-17-92 cluster expression are linked to poor prognosis in multiple myelomaLeukemia Res201236121505150922959509
  • YuGTangJQTianMLPrognostic values of the miR-17-92 cluster and its paralogs in colon cancerJ Surg Oncol2012106323223722065543
  • SaitoMSchetterAJMollerupSThe association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohortsClin Cancer Res20111771875188221350005
  • Valladares-AyerbesMBlancoMHazMPrognostic impact of disseminated tumor cells and microRNA-17-92 cluster deregulation in gastrointestinal cancerInt J Oncol20113951253126421743960
  • KomatsuSIchikawaDTsujiuraMPrognostic impact of circulating miR-21 in the plasma of patients with gastric carcinomaAnticancer Res201333127127623267156
  • ChenQSiQXiaoSPrognostic significance of serum miR-17-5p in lung cancerMed Oncol201330135323263848
  • ZhengJDongPGaoSWangNYuFHigh expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinomaHepatogastroenterology20136012354955223108086
  • ChenLJiangMYuanWTangHmiR-17-5p as a novel prognostic marker for hepatocellular carcinomaJ Invest Surg201225315616122583011
  • WangMGuHWangSCirculating miR-17-5p and miR-20a: Molecular markers for gastric cancerMol Med Rep2012561514152022406928
  • YuJOhuchidaKMizumotoKFujitaHNakataKTanakaMMicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasionCancer Biol Ther201010874875720703102
  • BusaccaSGermanoSDe CeccoLMicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implicationsAm J Respir Cell Mol Biol201042331231919502386
  • DíazRSilvaJGarcíaJMDeregulated expression of miR-106a predicts survival in human colon cancer patientsGenes Chromosomes Cancer200847979480218521848
  • ChoWCMicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapyInt J Biochem Cell Biol20104281273128120026422
  • ChoWCOncomiRs: the discovery and progress of microRNAs in cancersMol Cancer200766017894887
  • BrowneGTaipaleenmäkiHSteinGSSteinJLLianJBMicroRNAs in the control of metastatic bone diseaseTrends Endocrinol Metab201425632032724811921
  • BryantRJPawlowskiTCattoJWFChanges in circulating microRNA levels associated with prostate cancerBr J Cancer2012106476877422240788
  • JoosseSAMüllerVSteinbachBPantelKSchwarzenbachHCirculating cell-free cancer-testis MAGE-A RNA, BORIS RNA, let-7b and miR-202 in the blood of patients with breast cancer and benign breast diseasesBr J Cancer2014111590991724983365
  • ZampetakiAKiechlSDrozdovIPlasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetesCirc Res2010107681081720651284
  • YuZWangCWangMA Cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferationJ Cell Biol2008182350951718695042
  • ZhengZFSuHFZouYPengZWuSXExpression profiles of microRNAs in radioresistant esophageal cell lineZhonghua Yi Xue Za Zhi2011919639642 In Chinese21600139
  • DewsMHomayouniAYuDAugmentation of tumor angiogenesis by a Myc-activated microRNA clusterNat Genet20063891060106516878133
  • HossainAKuoMTSaundersGFmir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNAMol Cell Biol200626218191820116940181
  • ZhangWLinJWangPSunJmiR-17-5p down-regulation contributes to erlotinib resistance in non-small cell lung cancer cellsJ Drug Target201725212513127633093
  • YangXDuWWLiHBoth mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasionNucleic Acids Res201341219688970423990326
  • Lynam-LennonNHeaveySSommervilleGMicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotypeOncotarget2016871140011413
  • DiosdadoBWielMAVDDrosteJSTSmiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progressionBr J Cancer2009101470771419672269
  • Cuyun CarterGBarrettAMKayeJALiepaAMWinfreeKBJohnWJA comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancerCancer Manag Res2014643744925364274
  • BarkerEVCervigneNKReisPPmicroRNA evaluation of unknown primary lesions in the head and neckMol Cancer2009812720028561
  • JamaliZAsl AminabadiNAttaranRPournagiazarFGhertasi OskoueiSAhmadpourFMicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysisOral Oncol201551432133125677760